Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E

[1]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[2]  R. Mahley,et al.  Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.

[3]  E. Wijsman,et al.  The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. , 1994, American journal of human genetics.

[4]  D. Schaid,et al.  Apolipoprotein E: risk factor for Alzheimer disease. , 1994, American journal of human genetics.

[5]  W. Engel,et al.  Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases , 1994, The Lancet.

[6]  Margaret A. Pericak-Vance,et al.  Hypothesis: Microtubule Instability and Paired Helical Filament Formation in the Alzheimer Disease Brain Are Related to Apolipoprotein E Genotype , 1994, Experimental Neurology.

[7]  P. Amouyel,et al.  Confirmation of the ϵ4 allele of the apolipoprotein E gene as a risk factor for late‐onset Alzheimer's disease , 1994, Neurology.

[8]  J. Fink,et al.  ApoE ϵ4 allelic association with Alzheimer's disease , 1994, Neurology.

[9]  D. Selkoe,et al.  Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide , 1993, Cell.

[10]  B. Tycko,et al.  The apolipoprotein ε4 allele in patients with Alzheimer's disease , 1993, Annals of neurology.

[11]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[12]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[13]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[15]  R. Crowther.  Tau protein and paired helical filaments of Alzheimer's disease , 1993 .

[16]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  N. Maeda,et al.  Nerve Regeneration Occurs in the Absence of Apolipoprotein E in Mice , 1993, Journal of neurochemistry.

[18]  G. Handelmann,et al.  Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. , 1992, Journal of lipid research.

[19]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[20]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[21]  D A Agard,et al.  Three-dimensional structure of the LDL receptor-binding domain of human apolipoprotein E. , 1991, Science.

[22]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[23]  L. Notterpek,et al.  Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I. , 1990, The Journal of biological chemistry.

[24]  R. Havel,et al.  Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections. , 1990, Journal of lipid research.

[25]  K. Weisgraber.  Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112. , 1990, Journal of lipid research.

[26]  J. Fruchart,et al.  Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. , 1990, The Journal of biological chemistry.

[27]  E. Shooter,et al.  A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. , 1989, The Journal of clinical investigation.

[28]  K. Weisgraber,et al.  Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. , 1988, The Journal of biological chemistry.

[29]  K. Weisgraber,et al.  Human apolipoprotein E3 in aqueous solution. II. Properties of the amino- and carboxyl-terminal domains. , 1988, The Journal of biological chemistry.

[30]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[31]  R. E. Pitas,et al.  Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. , 1987, The Journal of biological chemistry.

[32]  R. Mahley,et al.  Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. , 1987, Biochimica et biophysica acta.

[33]  R. Gregg,et al.  Abnormal in vivo metabolism of apolipoprotein E4 in humans. , 1986, The Journal of clinical investigation.

[34]  E. Shooter,et al.  Expression of apolipoprotein E during nerve degeneration and regeneration. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[35]  E. Shooter,et al.  Expression of specific sheath cell proteins during peripheral nerve growth and regeneration in mammals , 1986, The Journal of cell biology.

[36]  J. Taylor,et al.  Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. , 1985, The Journal of clinical investigation.

[37]  E. Shooter,et al.  A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. , 1985, Science.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  R. Mahley,et al.  The receptor-binding domain of human apolipoprotein E. Binding of apolipoprotein E fragments. , 1983, The Journal of biological chemistry.

[40]  R. Mahley,et al.  The receptor-binding domain of human apolipoprotein E. Monoclonal antibody inhibition of binding. , 1983, The Journal of biological chemistry.

[41]  E. Shooter,et al.  Denervated sheath cells secrete a new protein after nerve injury. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Mahley,et al.  Human apolipoprotein E. The complete amino acid sequence. , 1982, The Journal of biological chemistry.

[43]  R. Mahley,et al.  Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. , 1981, The Journal of biological chemistry.

[44]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[45]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[46]  K. Weisgraber.  Apolipoprotein E: structure-function relationships. , 1994, Advances in protein chemistry.

[47]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[48]  J. Taylor,et al.  Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.